Baker Bros. Capital (GP), LLC Insider Trading $VPHM VIROPHARMA INC
Get free email notifications about insider trading for Baker Bros. Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Bros. Capital (GP), LLC. Baker Bros. Capital (GP), LLC is 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in TAPESTRY PHARMACEUTICALS, INC ($NPRO) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Baker Bros. Capital (GP), LLC in VIROPHARMA INC
Trading Symbol: VPHMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Bros. Capital (GP), LLC: 10% Owner
Holdings: 4,751 shares
Latest Transaction: May 13 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Bros. Capital (GP), LLC in VIROPHARMA INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, HRTX, IDRA, INCY, NRGN, SGEN, GEVA, NPRO, VPHM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2011 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 101,047 | 0 | 4,751 | 105.8 K to 4.8 K (-95.51 %) |
May 26 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.10 | 2 | 12 | 105,798 | 105.8 K to 105.8 K (0.00 %) |
May 26 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.08 | 11 | 67 | 105,796 | 105.8 K to 105.8 K (+0.01 %) |
May 26 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.08 | 11 | 67 | 105,785 | 105.8 K to 105.8 K (+0.01 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.00 | 31 | 186 | 105,774 | 105.7 K to 105.8 K (+0.03 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.98 | 21 | 126 | 105,743 | 105.7 K to 105.7 K (+0.02 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.99 | 15 | 90 | 105,722 | 105.7 K to 105.7 K (+0.01 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.84 | 3 | 18 | 105,707 | 105.7 K to 105.7 K (0.00 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.87 | 10 | 59 | 105,704 | 105.7 K to 105.7 K (+0.01 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 6.00 | 28 | 168 | 105,694 | 105.7 K to 105.7 K (+0.03 %) |
May 15 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.46 | 190 | 1,037 | 105,666 | 105.5 K to 105.7 K (+0.18 %) |
May 15 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.46 | 44 | 240 | 105,476 | 105.4 K to 105.5 K (+0.04 %) |
May 15 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.45 | 45 | 245 | 105,432 | 105.4 K to 105.4 K (+0.04 %) |
May 11 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.86 | 61 | 357 | 105,387 | 105.3 K to 105.4 K (+0.06 %) |
May 11 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.92 | 83 | 492 | 105,326 | 105.2 K to 105.3 K (+0.08 %) |
May 11 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.73 | 48 | 275 | 105,243 | 105.2 K to 105.2 K (+0.05 %) |
May 11 2009 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 5.72 | 90 | 515 | 105,195 | 105.1 K to 105.2 K (+0.09 %) |
Oct 21 2008 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | J | 2.74 | 27 | 74 | 125,492 | 125.5 K to 125.5 K (+0.02 %) |
May 30 2008 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 697 | 0 | 125,465 | 126.2 K to 125.5 K (-0.55 %) |
May 30 2008 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | J | 0.00 | 17,965 | 0 | 126,162 | 144.1 K to 126.2 K (-12.46 %) |
Mar 17 2008 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 8.14 | 15 | 122 | 144,127 | 144.1 K to 144.1 K (+0.01 %) |
Mar 17 2008 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 8.67 | 9 | 78 | 144,112 | 144.1 K to 144.1 K (+0.01 %) |
Mar 17 2008 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 8.69 | 134 | 1,165 | 144,103 | 144 K to 144.1 K (+0.09 %) |
Jan 10 2008 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 8.95 | 192 | 1,718 | 143,969 | 143.8 K to 144 K (+0.13 %) |
Jan 10 2008 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 8.76 | 281 | 2,461 | 143,777 | 143.5 K to 143.8 K (+0.20 %) |
Nov 09 2007 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 7.63 | 532 | 4,060 | 143,496 | 143 K to 143.5 K (+0.37 %) |
Nov 09 2007 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 7.43 | 934 | 6,943 | 142,964 | 142 K to 143 K (+0.66 %) |
Nov 09 2007 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Buy | P | 7.27 | 747 | 5,434 | 142,030 | 141.3 K to 142 K (+0.53 %) |
Apr 17 2007 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 15.44 | 1,831 | 28,267 | 141,283 | 143.1 K to 141.3 K (-1.28 %) |
Apr 17 2007 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 15.45 | 64 | 989 | 143,114 | 143.2 K to 143.1 K (-0.04 %) |
Apr 17 2007 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 15.43 | 303 | 4,676 | 143,178 | 143.5 K to 143.2 K (-0.21 %) |
Apr 17 2007 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 15.54 | 337 | 5,238 | 143,481 | 143.8 K to 143.5 K (-0.23 %) |
Apr 17 2007 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 15.44 | 716 | 11,055 | 143,818 | 144.5 K to 143.8 K (-0.50 %) |
Apr 17 2007 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 15.30 | 4,195 | 64,193 | 144,534 | 148.7 K to 144.5 K (-2.82 %) |
Apr 17 2007 | VPHM | VIROPHARMA INC | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | S | 15.32 | 1,897 | 29,067 | 148,729 | 150.6 K to 148.7 K (-1.26 %) |
Page: 1